Large-scale testing (Phase 3)UnknownNCT06060301What this trial is testingTopical Sulfasalazine and Oral Lichen PlanusWho this might be right forOral Lichen PlanusTopical SulfasalazineCorticosteroids Cairo University 46
Not applicableActive Not RecruitingNCT06952465What this trial is testingA Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 2,000
Large-scale testing (Phase 3)Study completedNCT04632927What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor TreatmentWho this might be right forPsoriatic Arthritis Novartis Pharmaceuticals 119
Not applicableStudy completedNCT06135805What this trial is testingImpact of Fluocinonide 0,05% in Oral Lichen PlanusWho this might be right forOral Lichen Planus University of Catania 47
Early research (Phase 1)Study completedNCT03073213What this trial is testingIxekizumab in Chinese Participants With Psoriasis VulgarisWho this might be right forPsoriasis Eli Lilly and Company 32
Testing effectiveness (Phase 2)Study completedNCT04976673What this trial is testingComparison of Clinical Efficiency of Photodynamic Therapy and Topical Corticosteroid in Treatment of Oral Lichen PlanusWho this might be right forLichen Planus, Oral Wroclaw Medical University 30
Large-scale testing (Phase 3)Ended earlyNCT05623345What this trial is testingPsoriatic Arthritis Study of IzokibepWho this might be right forPsoriatic Arthritis ACELYRIN Inc. 351
Large-scale testing (Phase 3)Study completedNCT03721172What this trial is testingApremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and EfficacyWho this might be right forPsoriasis Amgen 595
Testing effectiveness (Phase 2)Study completedNCT04246372What this trial is testingTofacitinib for Immune Skin Conditions in Down SyndromeWho this might be right forDown SyndromeAlopecia AreataAtopic Dermatitis / Eczema+3 more University of Colorado, Denver 47
Testing effectiveness (Phase 2)Study completedNCT03975153What this trial is testingGuselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)Who this might be right forPityriasis Rubra Pilaris Oregon Health and Science University 15
Post-approval studies (Phase 4)Study completedNCT02187172What this trial is testingVascular Inflammation in Psoriasis-Ustekinumab (VIP-U)Who this might be right forPsoriasisCardiovascular Disease University of Pennsylvania 43
Testing effectiveness (Phase 2)Study completedNCT02173301What this trial is testingAssess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type PsoriasisWho this might be right forPsoriasis Dr. Reddy's Laboratories Limited 200
Not applicableStudy completedNCT02470481What this trial is testingA Study in Participants With Psoriatic Arthritis Attending Dermatology ClinicsWho this might be right forPsoriatic Arthritis Janssen Research & Development, LLC 250
Not applicableStudy completedNCT00710489What this trial is testingPotential Research Study Participant RegistryWho this might be right forAcneActinic KeratosisDysplastic Nevi+7 more University of California, Davis 265
Post-approval studies (Phase 4)Study completedNCT00312026What this trial is testingEvaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetWho this might be right forPsoriasis Genentech, Inc. 75
Not applicableStudy completedNCT06676176What this trial is testingPsoriatic Arthritis Pathobiology and Its Relationship With Clinical Disease ActivityWho this might be right forArthritis, Psoriatic Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Study completedNCT03832738What this trial is testingStudy to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasisSkin Diseases Akros Pharma Inc. 152
Not applicableStudy completedNCT01768858What this trial is testingAssessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical PracticeWho this might be right forRheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more AbbVie 96
Large-scale testing (Phase 3)Study completedNCT01406938What this trial is testingEfficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose RegimensWho this might be right forModerate to Severe Plaque-type Psoriasis Novartis Pharmaceuticals 967
Not applicableLooking for participantsNCT04080635What this trial is testingTherapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)Who this might be right forPsoriasis Vulgaris University Hospital, Ghent 100